Core Laboratories NV (NYSE:CLB) shares gapped up before the market opened on Friday . The stock had previously closed at $110.72, but opened at $111.43. Core Laboratories NV shares last traded at $112.96, with a volume of 160,205 shares trading hands.

CLB has been the subject of a number of recent analyst reports. Citigroup Inc. boosted their target price on shares of Core Laboratories NV from $115.00 to $123.00 and gave the company a “neutral” rating in a research note on Monday, May 16th. Zacks Investment Research raised shares of Core Laboratories NV from a “sell” rating to a “hold” rating in a research note on Monday, May 16th. JPMorgan Chase & Co. initiated coverage on shares of Core Laboratories NV in a research note on Friday, June 10th. They set an “overweight” rating and a $120.00 target price for the company. KLR Group reissued a “buy” rating and set a $180.00 target price (up from $166.00) on shares of Core Laboratories NV in a research note on Monday, June 13th. Finally, Credit Suisse Group AG initiated coverage on shares of Core Laboratories NV in a research note on Thursday. They set a “neutral” rating and a $115.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $121.29.

The stock’s 50-day moving average is $117.13 and its 200-day moving average is $117.60. The company has a market cap of $4.95 billion and a PE ratio of 59.59.

Core Laboratories NV (NYSE:CLB) last released its earnings results on Wednesday, July 20th. The company reported $0.35 earnings per share for the quarter, meeting the consensus estimate of $0.35. The firm earned $148.10 million during the quarter, compared to analyst estimates of $146.37 million. The business’s revenue was down 27.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.81 earnings per share. Analysts forecast that Core Laboratories NV will post $1.57 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Monday, August 15th. Shareholders of record on Monday, July 18th were given a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 1.96%. The ex-dividend date was Thursday, July 14th.

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company’s services and products are directed toward enabling the Company’s clients to improve reservoir performance and increase oil and gas recovery from their producing fields.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.